2018

17/07/2018

Proteomics secures major contract – nears cash flow positive

21/06/2018

Further information on new licence deals in USA and Mexico

18/06/2018

Proteomics signs deal with Patia for PromarkerD in Mexico

28/05/2018

Proteomics signs deal to launch PromarkerD test in US market

22/05/2018

Appendix 3B – Issue of Employee Options

26/04/2018

PIQ Quarterly Business Update

19/04/2018

Europe PromarkerD patent granted for diabetic kidney disease

16/04/2018

Underwriters take final $342,000 of Proteomics Options

16/04/2018

Change in substantial holding

16/04/2018

Change in substantial holding

16/04/2018

Change in substantial holding

16/04/2018

Appendix 3B

16/04/2018

Secondary trading notice

06/04/2018

Conversion of 90% of Proteomics Options raises of $3m

06/04/2018

Secondary trading notice

06/04/2018

Change of Director’s Interest Notice

06/04/2018

Appendix 3B – Exercise of options

29/03/2018

Change of Director’s Interest Notice

29/03/2018

Secondary Trading Notice

29/03/2018

Appendix 3B – Exercise of options

23/03/2018

Directors Exercise PIQ Options

23/03/2018

Change of Directors’ Interest Notices

23/03/2018

Appendix 3B – Exercise of options

23/03/2018

Secondary Trading Notice

18/03/2018

Appendix 3B – Expiry of Options

14/03/2018

Proteomics secures underwriting – PIQ Options to raise $3.4m

08/03/2018

Secondary trading notice

08/03/2018

Appendix 3B

07/03/2018

Proteomics launches PromarkerD

05/03/2018

Proteomics completes investment in CPR Pharma Services

05/03/2018

Appendix 3B

05/03/2018

Secondary trading notice

19/02/2018

Expiry of Options – Letter to Option Holders

16/02/2018

Appendix 4D and Interim Financial Report

15/02/2018

Appendix 3B

07/02/2018

Proteomics International Investor Presentation

06/02/2018

Proteomics International Investor conference call

05/02/2018

Proteomics International Options PIQO Exercised

05/02/2018

Appendix 3B

02/02/2018

Strategic alliance and investment in CPR Pharma Services

29/01/2018

PromarkerD diabetic kidney disease patent granted in Japan

25/01/2018

Appendix 4C – December 2017 Quarterly Report

Subscribe
  • This field is for validation purposes and should be left unchanged.